NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)

CUSIP: 44975P103

Q4 2023 13F Holders as of 31 Dec 2023

Security type / class
Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
Total 13F shares
12,343,395
Total 13F value
$23,450,292
Holder snapshot 6 visible 7 signals
Share change
-2,597,698
Put/Call ratio
680%
SEC-reported price per share
$1.90
Number of holders
43
Value change
-$3,932,021
Number of buys
19
Open additional details 1 more signal available
Number of sells
27
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
265,214,861

Security key

44975P103

Report period

Q4 2023

Institutions

43

Top holders

10

NBP full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2024 Previous quarter: Q3 2023 NovaBridge Biosciences SEC filings NovaBridge Biosciences company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
HHLR ADVISORS, LTD.
Disclosed value leader
HHLR ADVISORS, LTD.
Comparable rows
15/15
Latest evidence
30 Sep 2023
13F Lead comparable stake: 2.6% Showing 1-6 of 15 holder rows.

Quick read

HHLR ADVISORS, LTD. leads the comparable SEC ownership view at 2.6%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens HHLR ADVISORS, LTD.'s linked filing trail.
Comparable ownership Top 5
HHLR ADVISORS, LTD. 2.6%
MORGAN STANLEY 0.37%
Artal Group S.A. 0.32%
BlackRock Finance, Inc. 0.27%
Temasek Holdings (Private) Ltd 0.21%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
HHLR ADVISORS, LTD.
13F
Company
13F
2.6%
$9,120,170
6,909,220 shares
 — 30 Sep 2023
MORGAN STANLEY
13F
Company
13F
0.37%
$1,305,059
988,681 shares
 — 30 Sep 2023
Artal Group S.A.
13F
Company
13F
0.32%
$1,122,000
850,000 shares
 — 30 Sep 2023
BlackRock Finance, Inc.
13F
Company
13F
0.27%
$954,730
723,280 shares
 — 30 Sep 2023
Temasek Holdings (Private) Ltd
13F
Company
13F
0.21%
$747,978
566,650 shares
 — 30 Sep 2023
UBS Group AG
13F
Company
13F
0.21%
$737,290
558,553 shares
 — 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
43
Shares
12,343,395
Rows available
43
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
46
Q4 2023 holders
43
Holder diff
-3
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .